Evidence map›Paper›PMID 42439178›Full record

ArticleChemistryOpen2026

Advantages of Asymmetry: A Synthetic and Structural Exploration of s-Triazine Chemistry Starting From Pyrrolated Ammeline and Melam.

Thaddäus J Koller, Alexander Pichler, Johannes N Singer, Zehua Xu, Vasiliki Valsamidou, Reinhard M Pritzl, Wolfgang Schnick

Abstract read
In one paragraph

Article in ChemistryOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Thaddäus J KollerDepartment of Chemistry, University of Munich (LMU), Munich, Germany.
Alexander PichlerDepartment of Chemistry, University of Munich (LMU), Munich, Germany.
Johannes N SingerDepartment of Chemistry, University of Munich (LMU), Munich, Germany.
Zehua XuDepartment of Chemistry, University of Munich (LMU), Munich, Germany.
Vasiliki ValsamidouDepartment of Chemistry, University of Munich (LMU), Munich, Germany.
Reinhard M PritzlDepartment of Chemistry, University of Munich (LMU), Munich, Germany.
Wolfgang SchnickDepartment of Chemistry, University of Munich (LMU), Munich, Germany.ORCID https://orcid.org/0000-0003-4571-8035

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melam and ammeline are simple, s-triazine-based compounds first described by Liebig nearly 200 years ago. Outgoing from these two compounds, synthetic strategies for asymmetrically substituted s-triazines were developed. As the initial key step, Clauson-Kaas pyrrolation of the compounds' primary amino groups was carried out, significantly improving their solubility in organic solvents and thereby facilitating further conversions. These include functionalization of the s-triazine bridging amino group of pyrrolated melam by reaction with electrophiles, while pyrrolated ammeline was deoxychlorinated and subsequently reacted with nucleophiles to displace the resulting Cl substituent. Moreover, a reaction protocol for reversion of pyrrolyl into amino groups was developed, which involved ozonolysis, followed by treatment with aqueous NaOCl of the resulting formamide derivatives. Thereby, melam derivatives with essentially the same coordination site but enhanced solubilities were obtained. This enabled the preparation of a Cu(II) coordination complex from aqueous solution, which is unheard of for melam itself. Finally, the thus accessible s-triazines were structurally characterized to gain deeper insights on how the different conducted transformations influence the physicochemical properties relevant for future applications.

Indexed as

azo compoundsN ligandsreaction mechanismssolid‐state structuressynthetic methods

Identifiers

PMID42439178
PMCPMC13359248

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.